Stephen Anderson
2010
In 2010, Stephen Anderson earned a total compensation of $221.8K as Former Chief Financial Officer at OncoGenex Pharmaceuticals, a 38% decrease compared to previous year.
Compensation breakdown
| Salary | $39,909 |
|---|---|
| Other | $181,904 |
| Total | $221,813 |
Anderson received $181.9K in other compensation, accounting for 82% of the total pay in 2010.
Anderson also received $39.9K in salary.
Rankings
In 2010, Stephen Anderson's compensation ranked 9,642nd out of 10,439 executives tracked by ExecPay. In other words, Anderson earned more than 7.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,642 out of 10,439 | 8th |
Division Manufacturing | 3,582 out of 3,838 | 7th |
Major group Chemicals And Allied Products | 859 out of 921 | 7th |
Industry group Drugs | 633 out of 680 | 7th |
Industry In Vitro and In Vivo Diagnostic Substances | 42 out of 51 | 18th |
Source: SEC filing on April 21, 2011.
Anderson's colleagues
We found three more compensation records of executives who worked with Stephen Anderson at OncoGenex Pharmaceuticals in 2010.